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Introduction
Many healthcare organizations have to report an increasing number of quality 
of care measures. The predominant method to model and solve such 
requirements is using SQL-based tools. However, existing database tools do 
not provide good support for solving time-related questions and SQL is not 
easily understood by clinicians. We used our previously developed analytical 
infrastructure called RetroGuide (RG) [1] to partially model two HEDIS 2007 
quality improvement (QI) criteria developed by National Committee on Quality 
Assurance (NCQA). We also looked beyond the measure definition and 
retrospectively simulated decision support rules to capture pertinent clinical 
scenarios. We used data from the Enterprise Data Warehouse (EDW) at 
Intermountain Healthcare (IHC). IHC is a not-for-profit integrated delivery 
system of 21 hospitals with an affiliated health plan.
Methods
• HEDIS2007 OMW measure definition: The percentage of women 67 years of 
age and older who suffered a fracture and who had either a bone mineral 
density (BMD) test or prescription for a drug to treat or prevent osteoporosis in 
the six months after date of the fracture. 
• HEDIS2007 CMC measure definition (modified): The percentage of patients 
18-75 years of age who were discharged alive for acute myocardial infarction, 
coronary artery bypass graft or percutaneous transluminal coronary 
angioplasty who had each of the following: (1) LDL-C screening performed 
(CMC-I measure) and (2) LDL-C control <100 mg/dL (CMC-II measure)
• Two selected measures were modeled in RetroGuide analytical suite inspired 
by workflow technology
• RetroGuide analytical suite uses the following steps (Figure 4) [2-6]:
Results
OMW: The RG output report showed that 7.96% of the patients had an osteoporosis 
drug prescription and 3.15% had a report about bone mineral density test within 6 
months from the fracture. In terms of potential areas for improvement, we found that 
21.96% of non-compliant women had an established prior diagnosis of osteoporosis (via 
ICD9 billing code or EHR problem list) and 11.2% had 2 or more encounters within 6 
months after the fracture. We also studied women with fracture at age 65 to 66 (prior to 
the measure-qualifying-age of 67) and found that 12.0% had a prior diagnosis of 
osteoporosis; 20.0% had an additional fracture prior to age 65; and 4.67% had a record 
of therapy prescription only after 2 or more previous fractures.
CMC: We found that 43.24% of CMC patients had proper cholesterol screening 
performed and 31.53% were in good control. We investigated what percentage was 
close to the threshold level (100-130 mg/dL) and on a low dose of a lipid-lowering agent 
(2.66%). In 13.38% of the non-compliant patients we found evidence of 2+ laboratory-
test-episodes or 3+ encounters within the desired time window. These results are limited 
by the presence of appropriate codes and completeness of the EHR available at IHC.
Discussion
RG’s key advantages are: (1) Graphical approach to modeling analytical 
questions. Such graphical middle layer facilitates better clinician-analyst 
collaboration (executable flowcharts will be included in the poster version); (2) 
Ability to model a set of criteria where parameters or results from previous 
restricting criterion can be easily used in subsequent criteria; (3) Ability to 
easily extent the HEDIS model with additional relevant analytical questions; 
and (4) Ability to prototype several versions of decision support on 
retrospective data and observe potential impact prior to deployment (with 
support for patient level execution trace and EHR drill down capabilities). (5) 
RetroGuide is based on cross-industry workflow technology with a potential to 
use different editors or engines for implementing similar analytical framework at 
different institutions and ability to share scenarios definition via standard 
process definition languages (e.g., XPDL).
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1. data extraction phase: assembly of chronologically ordered coded 
EHR event data for each cohort patient from various sources.
2. scenario modeling phase: creation of graphical executable model 
representing analytical steps. Scenario flowchart step-wise layer 
mimics a manual chart review process. Modeling constructs include 
use of nodes with links to external applications (code layer) and ability 
to use conditions on flowchart transition arrows (Figures 1,2 and 3). 
3. execution phase: sequential execution of the scenario on each cohort 
patient, creation of output reports (Figure 4)
4. reports review phase: hierarchy of linked reports showing execution of 
the lymphoma scenario on the real EHR data (Figures 5 and 6)
Figure 2: List of selected RG external applications which can be used inside flowchart nodes. External applications supports in and out parameters




















1. DataGet applications 2. Analytical applications
Fig 3: Main flowchart of the cholesterol screening scenario 
(CMC) shown in JaWE open-source workflow editor. Pink 
nodes contain subflows, gray nodes represent individual steps 
with references to one or more modular external applications 
(see Figure 1)
Fig 4 (on the right): RG analytical 
approach compared to SQL-based 
approach. RG scenario is constructed 
having single patient in mind and runs 
against data of individual patients (single 
patient execution strategy). RG results 
are hierarchical (3 levels of mandatory 
reports). Optional reports can be 
generated if appropriate RG external 
applications are used.
Fig.5: RG generated level 1 Summary report  shows 
population overview of results (for the OMW scenario). 
Only results of the  first 25 items are shown. The arrow 

























































































Fig. 6: RG generated, level 2 Execution trace report (OMW scenario) . In 
this report, each scenario step is audited (separately for each patient). The 
arrow shows the link to level 3 view of an EHR of an individual patient.
Fig 2: A) Main flowchart of the osteoporosis 
scenario (OMW) shown in the workflow editor (gray 
nodes include sub-flows).
B) Flowchart depicting individual steps and external 
applications involved in the sub-analysis 
investigating an alert logic for presence of 2+ 
encounters after index fracture event. 
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